(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

DANTARI

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

DANTARI

ST13

US500000088286373

Class

40

Filing

88286373

Registration

7026065

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

46

Latest update

04/11/2023

Trademark type

Word

Nice classes

40

Filing date

02/01/2019

Registration date

04/11/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/11/2023

Last transaction

04/11/2023

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

12/21/2020

First use in commerce

11/11/2021

Drawing code

4

Owner type

03

Owner location

Thousand Oaks, CA

Examiner

WOOD, CAROLINE

Law office

M10

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Dantari, Inc.
Dantari, Inc.

Representatives

Holly Pranger PRANGER LAW PC

Technical classification

Nice Classes

Class 40

Vienna Codes

No Vienna codes available.

Goods and services

Class 40

Biomanufacturing for othersmanufacturing of pharmaceuticals using biological organisms in the manufacturing process; providing technical information in the field of pharmaceutical manufacturing; custom manufacture of pharmaceuticals; custom manufacture of nanoscale material for use in the manufacture of other goods; custom manufacturing of pharmaceutical preparations for the treatment of disorders of the central nervous system; custom manufacturing of pharmaceutical preparations for the treatment of cancer; custom manufacture of pharmaceutical preparations that facilitate administration of other pharmaceutical preparations into the brain for enhanced treatment of disorders of the central nervous system and cancer

Publications

History of USPTO decisions and trademark events.

46 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

04/11/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

04/11/2023

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

03/08/2023

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

03/07/2023

SUPC

STATEMENT OF USE PROCESSING COMPLETE

02/06/2023

IUAF

USE AMENDMENT FILED

01/24/2023

EISU

TEAS STATEMENT OF USE RECEIVED

01/24/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

08/09/2022

EX5G

SOU EXTENSION 5 GRANTED

08/08/2022

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

08/06/2022

EXT5

SOU EXTENSION 5 FILED

07/25/2022

EEXT

SOU TEAS EXTENSION RECEIVED

07/25/2022

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

01/20/2022

EX4G

SOU EXTENSION 4 GRANTED

01/18/2022

EXT4

SOU EXTENSION 4 FILED

01/18/2022

EEXT

SOU TEAS EXTENSION RECEIVED

01/18/2022

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

09/02/2021

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

09/02/2021

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

09/02/2021

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

07/20/2021

EX3G

SOU EXTENSION 3 GRANTED

07/17/2021

EXT3

SOU EXTENSION 3 FILED

07/17/2021

EEXT

SOU TEAS EXTENSION RECEIVED

07/17/2021

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

01/13/2021

EX2G

SOU EXTENSION 2 GRANTED

01/11/2021

EXT2

SOU EXTENSION 2 FILED

01/11/2021

EEXT

SOU TEAS EXTENSION RECEIVED

01/11/2021

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

07/04/2020

EX1G

SOU EXTENSION 1 GRANTED

07/02/2020

EXT1

SOU EXTENSION 1 FILED

07/02/2020

EEXT

SOU TEAS EXTENSION RECEIVED

07/02/2020

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

01/28/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/03/2019

PUBO

PUBLISHED FOR OPPOSITION

12/03/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/13/2019

ALIE

ASSIGNED TO LIE

10/30/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/24/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/18/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/16/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/16/2019

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

04/17/2019

GNRT

NON-FINAL ACTION E-MAILED

04/17/2019

CNRT

NON-FINAL ACTION WRITTEN

04/17/2019

DOCK

ASSIGNED TO EXAMINER

04/15/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

02/25/2019

NWAP

NEW APPLICATION ENTERED

02/05/2019

Continuous trademark protection

Get notified about every new filing that threatens DANTARI or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.